Daily FNArena News

Orica believes its technological breakthrough should offer a competitive advantage and contribute to earnings growth in FY21. Yet brokers assess the positive outlook is already factored into the shares.

Credit Corp delivered its traditionally conservative guidance at its FY19 results and brokers assess where the upside may lie.

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. CIMIC Group has been hampered by soft activity in Hong Kong and timing of Australian projects.

Michael Gable of Fairmont Equities suggests Nanosonics should continue higher from here.

Super members want government to lead on multiple accounts and default funds.

After a strong FY19, sleep apnoea specialist ResMed is expected to make further inroads into market share in FY20 with its “connected-care” strategy.

Weaker economic conditions and increased competition look like hampering automotive and water product distributor GUD Holdings in the year ahead.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

Craig Parker of Moat Capital is confident a downturn for the ASX200 is ahead but it may yet take weeks.

Will iron ore prices peak soon? Several brokers ponder the outlook for Fortescue Metals, with the stock heavily leveraged to the fortunes of the commodity.